Adam H. Schechter, President and CEO of Labcorp Holdings Inc., filed a Form 4 on August 12, 2026, disclosing the sale of 4,669 shares of common stock on August 11, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Adam H. Schechter, President and CEO, and Director of Labcorp Holdings Inc.
  • Shares sold: 4,669 shares of common stock disposed of (transaction code S) on August 11, 2026.
  • Sale price: $320.37 per share.
  • Remaining ownership: 102,565 shares of common stock beneficially owned directly following the transaction.
  • 10b5-1 plan: The transaction was made pursuant to a plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
  • Filing signed: By Kathryn W. Kyle, Attorney-in-Fact for Adam H. Schechter, on August 12, 2026.

Schechter's Share Sale Details and Post-Transaction Ownership at Labcorp

According to the filing, Adam H. Schechter, who serves as both President and CEO and as a Director of Labcorp Holdings Inc. (NYSE:LH), sold 4,669 shares of the company's common stock on August 11, 2026, at a price of $320.37 per share. The transaction is recorded as a disposition (code "S") in Table I of the Form 4, with direct ownership indicated.

The filing notes that the sale was made "pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended." The Form 4 also indicates, via the checked box on the cover, that the transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Following the reported transaction, Schechter directly held 102,565 shares of Labcorp common stock, according to the filing.

No derivative securities transactions were reported in Table II of the filing. The Form 4 was filed by one reporting person and was signed by Kathryn W. Kyle as Attorney-in-Fact for Adam H. Schechter. The date of earliest transaction is listed as August 11, 2026, and the form was filed on August 12, 2026.

What Was Disclosed

The filing disclosed a single open-market sale of 4,669 shares of Labcorp Holdings common stock by CEO Adam H. Schechter at $320.37 per share on August 11, 2026, under a pre-established Rule 10b5-1 plan, leaving him with 102,565 directly held shares.